South San Francisco, CA, United States of America

Marian Seto

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marian Seto. Retrieved from https://idiyas.com/inventor/marian-seto-r21nchc4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marian Seto: Innovator in Receptor Tyrosine Kinases

Introduction

Marian Seto is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biochemistry, particularly in the development of synthetic ligands for receptor tyrosine kinases. Her innovative work has the potential to impact various therapeutic applications.

Latest Patents

Marian Seto holds a patent for "Modified ligands for receptor tyrosine kinases." This invention provides synthetic ligands that bind to class I receptor tyrosine kinases. The ligands are structurally analogous to naturally occurring ligands. However, the modified ligands eliminate the mid-sequence (B) domain present in the native ligands and replace it with a peptide bridge that links the amino (A) and carboxy (C) domains. She has 1 patent to her name.

Career Highlights

Marian Seto has worked at Schering Aktiengesellschaft, where she has been involved in groundbreaking research and development. Her expertise in receptor tyrosine kinases has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Marian has collaborated with notable colleagues, including Richard N Harkins and Bradley A Katz. These partnerships have fostered innovation and contributed to the advancement of their shared research goals.

Conclusion

Marian Seto is a distinguished inventor whose work in synthetic ligands for receptor tyrosine kinases showcases her innovative spirit and dedication to scientific advancement. Her contributions continue to influence the field of biochemistry and hold promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…